Corea de Sydenham: presentación de un caso tratado con carbamazepina con excelente respuesta clínica

Sydenham's chorea is the most common cause of acquired chorea in childhood. This disorder is secondary to an autoimmune response against basal ganglia in the brain, induced by prior streptococcal infection. Chorea is a major criterion for the diagnosis of rheumatic fever and can also be the presenting feature of the disease. The incidence of rheumatic fever has been markedly decreased by improved socioeconomic conditions and increased antibiotic prescription. In the last two decades, however, this disease has reappeared and should be taken into account in the evaluation of children with movement disorders. Chorea is characterized by acute exacerbations that can cause substantial functional impairment and may warrant drug treatment. Carbamazepine has proven to be both efficacious and safe in the treatment of this condition. We present a case of rheumatic chorea, in which carbamazepine therapy produced excellent clinical response.

[1]  A. Teixeira,et al.  Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea , 2005, Neurology.

[2]  K. Bhatia,et al.  Tracing Sydenham’s chorea: historical documents from a British paediatric hospital , 2005, Archives of Disease in Childhood.

[3]  J. Barash,et al.  Corticosteroid treatment in patients with Sydenham's chorea. , 2005, Pediatric neurology.

[4]  P. V. González,et al.  Corea de Sydenham: Análisis clínico de 55 pacientes con seguimiento prolongado , 2004 .

[5]  H. Lederman,et al.  Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea , 2003, Neuroradiology.

[6]  A J Lees,et al.  Anti–basal ganglia antibodies in acute and persistent Sydenham’s chorea , 2002, Neurology.

[7]  O. Molina,et al.  Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients. , 2002, Arquivos de neuro-psiquiatria.

[8]  B. Şaylan,et al.  Sydenham's chorea: clinical findings and comparison of the efficacies of sodium valproate and carbamazepine regimens , 2002, Brain and Development.

[9]  Jean Aicardi,et al.  Movement Disorders in Children , 2001 .

[10]  B. Volovitz,et al.  Successful treatment of rheumatic chorea with carbamazepine. , 2000, Pediatric neurology.

[11]  P. Vieco,et al.  Sydenham Chorea , 1997, Neurology.

[12]  J. A. Pallarés,et al.  Utilización de la carbamazepina en la coreoatetosis paroxística y en la corea de Sydenham , 1989 .

[13]  M. Roig,et al.  Carbamazepine: an alternative drug for the treatment of nonhereditary chorea. , 1988, Pediatrics.

[14]  S. Naidu,et al.  Sydenham's chorea: A possible presynaptic dopaminergic dysfunction initially , 1980, Annals of Neurology.